Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY is a research paper published in Diabetes Care (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDDK NIH HHS
Grant: P30 DK092926
NIDDK NIH HHS
Grant: R01 DK125513
NIDDK NIH HHS
Grant: U54 DK118612
NIDDK NIH HHS
Grant: P30 DK020572
National Institutes of Health
Grant: 5R01DK125513-03
Mechanisms of adipocyte loss in laminopathy-induced lipodystrophy in mice and humans
National Institutes of Health
Grant: 5U54DK118612-04
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-BIO/29266/2017
Deep Drug Discovery and Deployment
Fields of Study
MeSH Terms
Keywords